Global AI in Imaging and Diagnostics Market Size (2024 – 2030)

The Global AI in Imaging and Diagnostics Market is anticipated to witness substantial growth from 2024 to 2030, with an estimated value of USD 16.73 billion by the end of the forecast period, reflecting a robust CAGR of 26.2% compared to the initial valuation of USD 3.28 billion, as indicated by recent research findings.

Industry Overview

The anticipated growth trajectory of the AI in imaging and diagnostics market is attributed to demographic shifts, notably the expanding aging population, coupled with increased investments in healthcare infrastructure globally. Developed nations, facing the challenge of an aging populace, have directed efforts toward providing accessible and enhanced healthcare services, thereby fostering market expansion. Notably, conditions such as lung and breast cancer are frequently diagnosed through X-ray imaging, while computed tomography (CT) scans offer enhanced detection capabilities for subtle lung abnormalities, augmenting the role of medical imaging in diagnostics and treatment confirmation.

Moreover, the prevalence of various ailments, including fractures, infections, cancer, and arthritis, further propels the demand for X-ray imaging technologies. The projected rise in the incidence of such conditions, particularly among the elderly population, is expected to drive market growth. The integration of artificial intelligence (AI) holds promise in enhancing precision medicine through the analysis of extensive datasets encompassing diverse biological and clinical parameters concurrently, thereby enriching diagnostic accuracy and treatment outcomes.

The convergence of medical imaging devices with cloud-based platforms, facilitated by AI algorithms, is poised to revolutionize diagnostic practices by enabling automated screening, analysis, and interpretation of patient data. Notably, regions with limited radiologist availability, such as Mexico, stand to benefit significantly from AI-driven medical imaging solutions. Notable advancements in AI technology, exemplified by IBM Watson Health's AI platform for medical imaging analysis, underscore the growing adoption of AI-driven solutions in healthcare.

Impact of COVID-19

The COVID-19 pandemic has accelerated the adoption of AI technologies in healthcare, particularly in diagnostic imaging, to meet the escalating demand for efficient screening and diagnosis. AI-enabled tools, including radiomics and AI algorithms, have been instrumental in enhancing the accuracy and efficiency of diagnostic imaging techniques, such as X-ray and CT scans, for detecting COVID-19 symptoms. Healthcare facilities worldwide have leveraged AI-driven solutions for patient screening, triaging, and remote monitoring, thereby optimizing resource allocation and minimizing human contact, critical in containing the spread of the virus.

Market Drivers

A growing number of cross-industry collaborations and partnerships is boosting the market for AI in Imaging and Diagnostics

The market for AI in imaging and diagnostics is propelled by burgeoning cross-industry collaborations and partnerships, facilitating the development of innovative AI-based solutions tailored for healthcare applications. Key players in the healthcare sector are forging strategic alliances with leading AI technology providers to capitalize on the myriad benefits offered by AI methodologies, thereby enhancing their competitive position in the market.

Emerging Markets

Emerging economies, notably India, China, and Brazil, present lucrative growth opportunities for AI in medical diagnostics, driven by the burgeoning patient population and expanding healthcare infrastructure. Rising healthcare expenditures and the adoption of advanced medical technologies, including sophisticated imaging equipment, underscore the significant growth potential of these regions.

Market Challenges

Despite the promising growth prospects, the reluctance of medical professionals to embrace AI-based technologies poses a significant challenge to market expansion.

Concerns regarding the perceived threat of AI replacing human expertise, coupled with apprehensions regarding patient reliance on technology over traditional medical interventions, underscore the need for concerted efforts to address prevailing skepticism and foster trust in AI-driven healthcare solutions.

Global AI in Imaging and Diagnostics Market - By Components

• Hardware
• Software
• Services

The segmentation of the market into Hardware, Software, and Services is based on its components. In 2021, software dominated the market share, with a projected Compound Annual Growth Rate (CAGR) of 36.04% throughout the forecast period. The prominence of software in this sector is attributed to the advancements in AI-based diagnostic software, which significantly enhance diagnostic accuracy in healthcare. Within the software market, segments such as AI Platforms and AI Solutions are under scrutiny. The market's growth is primarily propelled by the escalating demand for AI-driven and cloud-based diagnostic solutions, which contribute to refining diagnostic precision when interpreting medical images of patients.

Global AI in Imaging and Diagnostics Market - By Technology

• Machine Learning
• NLP
• Context-Aware Computing
• Computer Vision

The market's categorization into Machine Learning, Natural Language Processing (NLP), Context-Aware Computing, and Computer Vision is based on technology. Computer Vision claimed the largest market share and is anticipated to expand at a CAGR of 31.87% over the forecast period. In 2021, Machine Learning held the second-largest market share and is forecasted to exhibit the most rapid growth rate.

Global AI in Imaging and Diagnostics Market - By Diagnosis Type

• Radiology
• Oncology
• Neurology & Cardiology
• Chest & Lungs
• Pathology
• Others

The market's division into Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others is based on diagnosis type. In 2021, Neurology & Cardiology accounted for the largest market share, with an expected CAGR of 33.52% during the forecast period. The integration of artificial intelligence (AI) is reshaping the landscape of healthcare, particularly in neurology. Over recent years, various AI applications targeting neurovascular diseases have been explored and even commercialized as software packages. Additionally, AI is revolutionizing cardiac care by enabling rapid, cost-effective, and accurate anticipation of electrocardiogram (ECG) irregularities, eliminating the need for the third invasive step in cardiovascular disease (CVD) diagnosis.

Global AI in Imaging and Diagnostics Market - By Geography & Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

The market is segmented into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. In 2021, North America dominated the market share, while Europe followed as the second-largest market. The increased utilization of artificial intelligence (AI) in healthcare is attributed to the growing complexity and volume of healthcare data. In North America, stakeholders including payers, care providers, and life sciences companies are increasingly adopting various forms of AI. Numerous hospitals across the United States and Canada have started leveraging machine learning for predictive analytics in hospital management, enabling proactive measures to prepare for anticipated events.

Global AI in Imaging and Diagnostics Market - By Companies

1. Aidence
2. Butterfly Network, Inc.
3. Day Zero Diagnostics
4. Digital Diagnostics (Formerly Known as Idx)
5. Enlitic
6. GE Healthcare
7. Google (Subsidiary of Alphabet, Inc.)
8. Heartflow
9. IBM
10. Informationalai
11. Intel
12. Microsoft Corporation
13. Nvidia
14. Prognos
15. Quibim

 RECENT DEVELOPMENTS IN THE GLOBAL DIGITAL AI IN THE IMAGING AND DIAGNOSTICS MARKET:

• Merger & Acquisition: In June 2021, AliveCor acquired CardioLabs, facilitating the advancement of Advanced Ambulatory Monitoring Services. This acquisition provides CardioLabs clients access to KardiaMobile 6L by AliveCor, the world's first wireless, patchless, six-lead cardiac monitor.
• Business Expansion: In May 2021, Unfallkrankenhaus Berlin introduced AI to Germany through Aidocto expand its footprint in Europe. The Unfallkrankenhaus Berlin (UK) opted for AIdoc's complete range of AI solutions to aid in prioritizing and expediting treatment for patients with life-threatening and urgent conditions.
• Business Collaboration: In July 2020, TELUS Ventures and Zebra Medical Vision announced their strategic partnership. This collaboration involves an investment to support Zebra-Med's expansion in North America and demonstrate its AI solutions across cutting-edge modalities and clinical care settings.